Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial-Reference-Cited by-同舟云学术

Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial

Published:2016-09-27 Issue: Volume: Page:i4935
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Leonardi Sergio,Frigoli Enrico,Rothenbühler Martina,Navarese Eliano,Calabró Paolo,Bellotti Paolo,Briguori Carlo,Ferlini Marco,Cortese Bernardo,Lupi Alessandro,Lerna Salvatore,Zavallonito-Parenti Dennis,Esposito Giovanni,Tresoldi Simone,Zingarelli Antonio,Rigattieri Stefano,Palmieri Cataldo,Liso Armando,Abate Fabio,Zimarino Marco,Comeglio Marco,Gabrielli Gabriele,Chieffo Alaide,Brugaletta Salvatore,Mauro Ciro,Van Mieghem Nicolas M,Heg Dik,Jüni Peter,Windecker Stephan,Valgimigli Marco

Publisher

BMJ

Subject

General Engineering

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis;American Journal of Cardiovascular Drugs;2024-04-29

2. Bivalirudin in patients with ST-segment elevation myocardial infarction;The Lancet;2022-11

3. Rationale and Design of a Randomized Controlled Trial of Bivalirudin with a Prolonged High-Dose Infusion Versus Heparin Monotherapy During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction: The BRIGHT-4 Trial;Cardiology Discovery;2022-08-23

4. Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK);Der Kardiologe;2021-09-21

5. A Meta-analysis of Clinical Trials Evaluating the Impact of Bivalirudin-based Anticoagulation for Primary Percutaneous Coronary on Long-Term Mortality;Journal of Cardiovascular Pharmacology;2021-07